NO20041840L - Rosuvastatin ved predemente tilstander - Google Patents

Rosuvastatin ved predemente tilstander

Info

Publication number
NO20041840L
NO20041840L NO20041840A NO20041840A NO20041840L NO 20041840 L NO20041840 L NO 20041840L NO 20041840 A NO20041840 A NO 20041840A NO 20041840 A NO20041840 A NO 20041840A NO 20041840 L NO20041840 L NO 20041840L
Authority
NO
Norway
Prior art keywords
predement
rosuvastatin
conditions
predement conditions
Prior art date
Application number
NO20041840A
Other languages
English (en)
Norwegian (no)
Inventor
Timothy Martin Piser
Hans Basun
Thor Rak
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20041840L publication Critical patent/NO20041840L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
NO20041840A 2001-10-19 2004-05-05 Rosuvastatin ved predemente tilstander NO20041840L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103509A SE0103509D0 (sv) 2001-10-19 2001-10-19 Rosuvastatin in pre demented states
PCT/SE2002/001911 WO2003032995A1 (en) 2001-10-19 2002-10-18 Rosuvastatin in pre demented states

Publications (1)

Publication Number Publication Date
NO20041840L true NO20041840L (no) 2004-05-05

Family

ID=20285721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041840A NO20041840L (no) 2001-10-19 2004-05-05 Rosuvastatin ved predemente tilstander

Country Status (19)

Country Link
US (1) US20060229321A1 (is)
EP (1) EP1446123A1 (is)
JP (1) JP2005505605A (is)
KR (1) KR20040058201A (is)
CN (1) CN1604780A (is)
AR (1) AR036891A1 (is)
BR (1) BR0213434A (is)
CA (1) CA2463597A1 (is)
CO (1) CO5580773A2 (is)
HU (1) HUP0401798A3 (is)
IL (1) IL161380A0 (is)
IS (1) IS7218A (is)
MX (1) MXPA04003631A (is)
NO (1) NO20041840L (is)
PL (1) PL369573A1 (is)
RU (1) RU2004112422A (is)
SE (1) SE0103509D0 (is)
WO (1) WO2003032995A1 (is)
ZA (1) ZA200402844B (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2537271A1 (en) 2003-08-28 2005-03-17 Teva Pharmaceutical Industries, Ltd. Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
WO2005051921A1 (en) 2003-11-24 2005-06-09 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
KR100887264B1 (ko) 2003-12-02 2009-03-06 테바 파마슈티컬 인더스트리즈 리미티드 로수바스타틴의 특성화를 위한 기준 표준물
US7179916B2 (en) 2004-07-13 2007-02-20 Teva Pharmaceutical Industries Ltd. Process for the preparation of rosuvastatin
CA2683975A1 (en) 2005-02-22 2006-08-31 Teva Pharmaceutical Industries Ltd. Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
US7868169B2 (en) 2005-08-16 2011-01-11 Teva Pharmaceutical Industries, Ltd. Crystalline rosuvastatin intermediate
WO2012073256A1 (en) 2010-11-29 2012-06-07 Cadila Healthcare Limited Salts of rosuvastatin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
AR022462A1 (es) * 1999-02-06 2002-09-04 Astrazeneca Uk Ltd Uso de un agente que disminuye el colesterol
US20030100493A1 (en) * 2001-07-19 2003-05-29 Sol Weiss Sublingual use of inhibitors in the biosynthesis of cholesterol

Also Published As

Publication number Publication date
IS7218A (is) 2004-04-13
KR20040058201A (ko) 2004-07-03
RU2004112422A (ru) 2005-04-10
IL161380A0 (en) 2004-09-27
WO2003032995A1 (en) 2003-04-24
EP1446123A1 (en) 2004-08-18
US20060229321A1 (en) 2006-10-12
BR0213434A (pt) 2004-11-09
PL369573A1 (en) 2005-05-02
CN1604780A (zh) 2005-04-06
ZA200402844B (en) 2005-01-24
CA2463597A1 (en) 2003-04-24
HUP0401798A3 (en) 2005-06-28
AR036891A1 (es) 2004-10-13
JP2005505605A (ja) 2005-02-24
MXPA04003631A (es) 2004-07-30
WO2003032995A8 (en) 2004-06-03
CO5580773A2 (es) 2005-11-30
HUP0401798A2 (hu) 2005-01-28
SE0103509D0 (sv) 2001-10-19

Similar Documents

Publication Publication Date Title
DK1303496T3 (da) Pyrimidinderivater
NO20041747L (no) Iontoforeseapparat
NO20042742L (no) Pyrimidinforbindelser
DE60208051D1 (de) 3-substituierte-4-pyrimidonderivate
DE60233524D1 (de) Imediadaten
ATE381742T1 (de) Intelligente dokumente
DK1370424T4 (da) Værdidokument
DK1440152T3 (da) 5t4-ligand
DE50209410D1 (de) Kugelgelenk
FI4918U1 (fi) Auringonsäteilysuoja
NO20032291D0 (no) Pyrimidinderivater
DE60203465D1 (de) Dosierungssytem
NO20042919L (no) Fenylalkyner
FR2827943B3 (fr) Profile en c
ATA13992002A (de) Schlackengranulierungsanlage
FI5039U1 (fi) Kaihdinmekanismi
FI20010158A0 (fi) Mikroaaltoantennijärjestely
AT500276B1 (de) Radschwenksystem
ATA7462001A (de) Radspannwerk
ATA6162001A (de) Schneekette
FI5027U1 (fi) Yläpohjarakenne
ITMI20011624A0 (it) Timpano di tompagnatura
SE0102987D0 (sv) Länsa
FI5322U1 (fi) Kulmaosa
ES1048413Y (es) Estuche

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application